Diagnostic performance of F-18 FDG PET or PET/CT for detection of recurrent gastric cancer: a systematic review and meta-analysis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: This systematic review and meta-analysis investigated the diagnostic performance of F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) or PET/computed tomography (PET/CT) for the detection of disease recurrence after curative resection of gastric cancer. Methods: The PubMed and Embase databases, from the earliest available date of indexing through November 30, 2019, were searched for studies evaluating the diagnostic performance of F-18 FDG PET or PET/CT to detect recurrent disease after gastric cancer surgery. Results: Across 17 studies (1,732 patients), the pooled sensitivity for F-18 FDG PET or PET/CT was 0.82 (95% confidence interval [CI], 0.74–0.88) with heterogeneity of I2=76.5 (p<0.001), and the specificity was 0.86 (95% CI, 0.78–0.91) with heterogeneity of I2=94.2 (p<0.001). Likelihood ratio (LR) tests gave an overall positive LR of 6.0 (95% CI, 3.6–9.7) and negative LR of 0.2 (95% CI, 0.14–0.31). The pooled diagnostic odds ratio was 29 (95% CI, 13–63). The summary receiver operating characteristic curve indicates that the area under the curve was 0.91 (95% CI, 0.88–0.93). Conclusion: The current meta-analysis showed good sensitivity and specificity of F-18 FDG PET or PET/CT for detecting recurrent disease after curative resection of gastric cancer despite heterogeneity in ethnicity, recurrence rate, histology, and interpretation method.
Abstract
Background: This systematic review and meta-analysis investigated the diagnostic performance of F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) or PET/computed tomography (PET/CT) for the detection of disease recurrence after curative resection of gastric cancer. Methods: The PubMed and Embase databases, from the earliest available date of indexing through November 30, 2019, were searched for studies evaluating the diagnostic performance of F-18 FDG PET or PET/CT to detect recurrent disease after gastric cancer surgery. Results: Across 17 studies (1,732 patients), the pooled sensitivity for F-18 FDG PET or PET/CT was 0.82 (95% confidence interval [CI], 0.74–0.88) with heterogeneity of I2=76.5 (p<0.001), and the specificity was 0.86 (95% CI, 0.78–0.91) with heterogeneity of I2=94.2 (p<0.001). Likelihood ratio (LR) tests gave an overall positive LR of 6.0 (95% CI, 3.6–9.7) and negative LR of 0.2 (95% CI, 0.14–0.31). The pooled diagnostic odds ratio was 29 (95% CI, 13–63). The summary receiver operating characteristic curve indicates that the area under the curve was 0.91 (95% CI, 0.88–0.93). Conclusion: The current meta-analysis showed good sensitivity and specificity of F-18 FDG PET or PET/CT for detecting recurrent disease after curative resection of gastric cancer despite heterogeneity in ethnicity, recurrence rate, histology, and interpretation method.
참고문헌 (38)
- "Cancer fact sheet stomach: Globocan 2020" (2022)[URL]
- Korean Cancer Report 2020, "National Cancer Center", National Cancer Center, ~ (2022)
- Japanese Gastric Cancer Association, "Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)", Gastric Cancer, 26, pp.1~25 (2023)
- Park Sin Hye, "Epidemiology of Gastric Cancer in Korea: Trends in Incidence and Survival Based on Korea Central Cancer Registry Data (1999–2019)", Journal of Gastric Cancer, 22(3), pp.160~168 (2022), 대한위암학회[DOI]
- Blodgett TM, "PET", CT : form and function, 2007, pp.242, 360~385
- Czernin J, "Improvements in cancer staging with PET", CT : literature-based evidence as of September 2006, 2007, pp.48(1 Suppl), 78S~88S
- Bar-Shalom R, "Clinical performance of PET", CT in evaluation of cancer : additional value for diagnostic imaging and patient management, 2003, pp.44, 1200~1209
- Bilici A, "The role of ¹⁸F-FDG PET", CT in the assessment of suspected recurrent gastric cancer after initial surgical resection : can the results of FDG PET, Eur J Nucl Med Mol Imaging, pp.2011, 38[DOI]
- De Potter T, "Whole-body PET with FDG for the diagnosis of recurrent gastric cancer", Eur J Nucl Med Mol Imaging, 29, pp.525~529 (2002)
- Whiting PF, "QUADAS-2 : a revised tool for the quality assessment of diagnostic accuracy studies", Ann Intern Med, 155, pp.529~536 (2011)
- Glas AS, "The diagnostic odds ratio : a single indicator of test performance", J Clin Epidemiol, 56, pp.1129~1135 (2003)
- Thompson SG, "Why sources of heterogeneity in meta-analysis should be investigated", BMJ, 309, pp.1351~1355 (1994)
- Deeks JJ, "The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed", J Clin Epidemiol, 58, pp.882~893 (2005)
- Hamza TH, "The binomial distribution of meta-analysis was preferred to model within-study variability", J Clin Epidemiol, 61, pp.41~51 (2008)
- Reitsma JB, "Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews", J Clin Epidemiol, 58, pp.982~990 (2005)
- Rutter CM, "A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations", Stat Med, 20, pp.2865~2884 (2001)
- Lijmer JG, "Empirical evidence of design-related bias in studies of diagnostic tests", JAMA, 282, pp.1061~1066 (1999)
- Graziosi L, "Role of FDG-PET", CT in follow-up of patients treated with resective gastric surgery for tumour, 2011, pp.82, 125~129
- -FDG positron emission tomography, "Clin Radiol", 2003, 215~221
- 김대응, "Detecting the Recurrence of Gastric Cancer after Curative Resection: Comparison of FDG PET", CT and Contrast-Enhanced Abdominal CT, 2011, pp.26(7), 875~880[DOI]
- Kim SJ, "Primary tumor 18F-FDG avidity affects the performance of 18F-FDG PET", CT for detecting gastric cancer recurrence, 2016, pp.57, 544~550
- Kim JH, "Evaluation of recurrence in gastric carcinoma : comparison of contrast-enhanced computed tomography and positron emission tomography", computed tomography, 2017, pp.23, 6448~6456
- Ji Eun Lee, "The Role of 18^F-FDG PET", CT in the Evaluation of Gastric Cancer Recurrence after Curative Gastrectomy, 2011, pp.52(1), 81~88[DOI]
- Lee JW, "Role of 18F-FDG PET", CT in the pr ediction of gastric cancer recurrence after curative surgical resection, 2012, pp.39, 1425~1434
- Lee DY, "Performance of(18)F-FDG PET", CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients, 2014, pp.28, 789~795
- Lee JW, "Diagnostic performance of FDG PET", CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection, 2016, pp.43, 881~888
- Nakamoto Y, "Clinical value of whole-body FDG-PET for recurrent gastric cancer : a multicenter study", Jpn J Clin Oncol, 39, pp.297~302 (2009)
- Park MJ, "Detecting recurrence of gastric cancer : the value of FDG PET", CT, 2009, pp.34, 441~447
- Sharma P, "18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma : results from a Non-Oriental Asian population", Nucl Med Commun, 33, pp.960~966 (2012)
- Sim SH, "The role of PET", CT in detection of gastric cancer recurrence, 2009, pp.9, 73~
- Sun L, "Clinical role of 18F-fluorodeoxyglucose positron emission tomography", computed tomography in post-operative follow up of gastric cancer : initial results, 2008, pp.14, 4627~4632
- Yun M, "The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET", J Nucl Med, 46, pp.953~957 (2005)
- Lee JH, "Factors predicting peritoneal recurrence in advanced gastric cancer : implication for adjuvant intraperitoneal chemotherapy", Gastric Cancer, 17, pp.529~536 (2014)
- Whiting J, "Follow-up of gastric cancer : a review", Gastric Cancer, 9, pp.74~81 (2006)
- Kim KW, "Postoperative anatomic and pathologic findings at CT following gastrectomy", Radiographics, 22, pp.323~336 (2002)
- 임준석, "Comparison of CT and 18F-FDG PET for Detecting Peritoneal Metastasis on the Preoperative Evaluation for Gastric Carcinoma", Korean Journal of Radiology, 7(4), pp.249~256 (2006), 대한영상의학회
- Wu LM, "18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer : a systematic review and meta-analysis", J Gastroenterol Hepatol, 27, pp.472~480 (2012)
- Alakus H, "Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression", Nucl Med Commun, 31, pp.532~538 (2010)